Impact of Patient Characteristics on the Outcomes of Patients with Gastrointestinal Cancers Treated with Immune Checkpoint Inhibitors
Gastrointestinal (GI) cancers are a group of malignancies that globally account for a significant portion of cancer incidence and cancer-related death. Survival outcomes for esophageal, gastric, pancreatic, and hepatobiliary cancers remain poor, but new treatment paradigms are emerging with the adve...
Main Authors: | Hyejee Ohm, Omar Abdel-Rahman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/1/60 |
Similar Items
-
Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies
by: Anita Mazloom, et al.
Published: (2020-08-01) -
Immune Checkpoint Inhibitors-induced Thyroid Dysfunction in Patients with Advanced Malignancies
by: Muhammad Latif, et al.
Published: (2022-10-01) -
Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
by: Tongtong Zhang, et al.
Published: (2023-10-01) -
Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review
by: Ranferi Ocaña-Guzmán, et al.
Published: (2023-08-01) -
Editorial: The role of immune checkpoints in gastrointestinal diseases
by: Xiaofei Shen, et al.
Published: (2023-07-01)